Nomination Committee appointed in respect of AGM 2017 in Camurus

Lund — 28 October 2016 — According to the instruction for Nomination Committee
in Camurus AB adopted at the annual general meeting held on 3 May 2016, the
Nomination Committee for the annual general meeting shall be composed of
representatives of the three largest shareholders in terms of voting rights as
of 31 August, along with the Chairman of the Board of Directors. The composition
of the Nomination Committee has now been established, and Camurus today
announced that the Nomination Committee in respect of the AGM 2017 consists of
the following persons who together represent approximately 65 percent of the
number of shares and votes in the company based on the last known shareholder
information.

  · Martin Jonsson, representing Sandberg Development AB
  · Jan Andersson, representing Swedbank Robur Fonder
  · Pär Josefsson, representing Fredrik Tiberg, and
  · Per Olof Wallström, Chairman of the Board

The Nomination Committee’s proposals will be presented in the Notice to the
Annual General Meeting 2017 and on Camurus’ web site, www.camurus.com.

Shareholders who wish to submit proposals to the Nomination Committee are
welcome to contact the Nomination Committee at the company’s address. Proposals
shall be submitted in due time before the Annual General Meeting, but not later
than 31 January 2017, to ensure that the proposals can be considered by the
Nomination Committee.

About Camurus
Camurus is a Swedish research-based pharmaceutical company committed to
developing and commercializing innovative and differentiated medicines for the
treatment of severe and chronic conditions. New drug products with best-in-class
potential are conceived based on the proprietary FluidCrystal® drug delivery
technologies and an extensive R&D expertise. Camurus’ clinical pipeline includes
products for treatment of cancer, endocrine diseases, pain and addiction,
developed in-house and in collaboration with international pharmaceutical
companies. The company’s shares are listed on Nasdaq Stockholm under the ticker
“CAMX”. For more information, visit www.camurus.com.

For more information
Per Olof Wallström, Chairman of the Board
Tel. +46 709 42 95 20
p.o.wallstrom@telia.com

The information was submitted for publication at 07.00 a.m. CET on 28 October
2016.